LivaNova (LIVN) Change in Accured Expenses (2015 - 2026)

LivaNova (LIVN) reported Change in Accured Expenses of -$38.8 million for Q1 2026, down 27.05% on a YoY basis from -$53.1 million in Q1 2025, and down 271.52% sequentially from $22.6 million in Q4 2025.

LivaNova (LIVN) Change in Accured Expenses (2015 - 2026) Analysis & Trends

LivaNova (LIVN) has 12 years of Change in Accured Expenses data on file, last reported at -$38.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Accured Expenses fell 27.05% year-over-year to -$38.8 million; the trailing twelve-month figure through Mar 2026 stood at -$21.7 million (up 26.23% YoY), and the FY2025 full-year result was -$13.4 million, up 7.13% from the prior year.
  • Change in Accured Expenses slipped to -$38.8 million in Q1 2026, from $22.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $27.3 million in Q4 2023 to a low of -$38.8 million in Q1 2026.
  • A 5-year average of -$3.0 million and a median of -$2.7 million in 2025 frame the typical range for Change in Accured Expenses.
  • Peak annual rise in Change in Accured Expenses reached 2603.04% in 2022, while the deepest fall reached 641.8% in 2022.
  • Tracing LIVN's Change in Accured Expenses over 5 years: stood at $1.9 million in 2022, then jumped by 1346.9% to $27.3 million in 2023, then tumbled by 67.35% to $8.9 million in 2024, then jumped by 153.85% to $22.6 million in 2025, then tumbled by 271.52% to -$38.8 million in 2026.
  • Business Quant data shows LIVN's Change in Accured Expenses at -$38.8 million in Q1 2026, $22.6 million in Q4 2025, and -$2.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -654.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -512.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -347.10 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 145.10 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -250.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 21.07 Mn
10 LivaNova 4.40 Bn 3.86 Bn 243.75 Mn -38.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -38.77 Mn
Mar 31, 2026 -38.77 Mn
Dec 31, 2025 22.61 Mn
Dec 31, 2025 22.61 Mn
Sep 30, 2025 -2.88 Mn
Sep 30, 2025 -2.88 Mn
Jun 30, 2025 -2.66 Mn
Jun 30, 2025 -2.66 Mn
Mar 31, 2025 -30.52 Mn
Mar 31, 2025 -30.52 Mn
Dec 31, 2024 8.91 Mn
Dec 31, 2024 8.91 Mn
Sep 30, 2024 2.00 Mn
Sep 30, 2024 2.00 Mn
Jun 30, 2024 -9.80 Mn
Jun 30, 2024 -9.80 Mn
Mar 31, 2024 -15.58 Mn
Mar 31, 2024 -15.58 Mn
Dec 31, 2023 27.27 Mn
Dec 31, 2023 27.27 Mn